Abstract:ABSTRACT Clorobiocin is a well-known, highly effective inhibitor of DNA gyrase belonging to the aminocoumarin antibiotics. To identify potentially novel derivatives of this natural product, we conducted an untargeted investigation of clorobiocin biosynthesis in the known producer Streptomyces roseochromogenes DS 12.976 using LC-MS E , molecular networking, and analysis of fragmentation spectra. Previously undescribed clorobiocin derivatives uncovered in this study include bromobiocin, a variant halogenated with bromine instead of chlorine, hydroxylated clorobiocin, carrying an additional hydroxyl group on its 5-methyl-pyrrole 2-carboxyl moiety, and two other derivatives with modifications on their 3-dimethylallyl 4-hydroxybenzoate moieties. Furthermore, we identified several compounds not previously considered clorobiocin pathway products, which provide new insights into the clorobiocin biosynthetic pathway. By supplementing the medium with different concentrations of potassium bromide, we confirmed that the clorobiocin halogenase can utilize bromine instead of chlorine. The reaction, however, is impeded such that non-halogenated clorobiocin derivatives accumulate. Preliminary assays indicate that the antibacterial activity of bromobioin against Bacillus subtilis and efflux-impaired Escherichia coli matches that of clorobiocin. Our findings emphasize that yet unexplored compounds can be discovered from established strains and biosynthetic gene clusters by means of metabolomics analysis and highlight the utility of LC-MS E -based methods to contribute to unraveling natural product biosynthetic pathways. IMPORTANCE The aminocoumarin clorobiocin is a well-known gyrase inhibitor produced by the gram-positive bacterium Streptomyces roseochromogenes DS 12.976. To gain a deeper understanding of the biosynthetic pathway of this complex composite of three chemically distinct entities and the product spectrum, we chose a metabolite-centric approach. Employing high-resolution LC-MS E analysis, we investigated the pathway products in extracted culture supernatants of the natural producer. Novel pathway products were identified that expand our understanding of three aspects of the biosynthetic pathway, namely the modification of the noviose, transfer and methylation of the pyrrole 2-carboxyl moiety, and halogenation. For the first time, brominated products were detected. Their levels and the levels of non-halogenated products increased in medium supplemented with KBr. Based on the presented data, we propose that the enzyme promiscuity contributes to a broad product spectrum.

Biosynthesis of Clorobiocin: Investigation of the Transfer and Methylation of the Pyrrolyl-2-carboxyl Moiety

Acyl Transfer in Clorobiocin Biosynthesis: Involvement of Several Proteins in the Transfer of the Pyrrole-2-Carboxyl Moiety to the Deoxysugar

Clon6, A Novel Methyltransferase Catalysing the Methylation of the Pyrrole-2-Carboxyl Moiety of Clorobiocin

CloN2, a Novel Acyltransferase Involved in the Attachment of the Pyrrole-2-carboxyl Moiety to the Deoxysugar of Clorobiocin

Metabolic Engineering of Aminocoumarins: Inactivation of the Methyltransferase Gene Clop and Generation of New Clorobiocin Derivatives in a Heterologous Host

Clorobiocin Biosynthesis in Streptomyces: Identification of the Halogenase and Generation of Structural Analogs

Cloq, A Prenyltransferase Involved In Clorobiocin Biosynthesis

Effects of Deletions of Mbth-Like Genes on Clorobiocin Biosynthesis in Streptomyces Coelicolor.

A metabolomics perspective on clorobiocin biosynthesis: discovery of bromobiocin and novel derivatives through LC-MS E -based molecular networking

Biosynthesis of the unusual 5,5-gem-dimethyl-deoxysugar noviose: investigation of the C-methyltransferase gene cloU.

Molecular cloning and sequence analysis of the clorobiocin biosynthetic gene cluster: new insights into the biosynthesis of aminocoumarin antibiotics.

Novobiocin Biosynthesis: Inactivation of the Putative Regulatory Gene Nove and Heterologous Expression of Genes Involved in Aminocoumarin Ring Formation

Functional Analysis of Biosynthetic Genes of Aminocoumarins and Production of Hybrid Antibiotics

Molecular Cloning and Sequence Analysis of the Clorobiocin Biosynthetic Gene Cluster: New Insights into the Biosynthesis of Aminocoumarin Antibiotics the GenBank Accession Number for the Sequence of Cosmid K1F2 is AF329398.

Antimicrobial and DNA Gyrase-Inhibitory Activities of Novel Clorobiocin Derivatives Produced by Mutasynthesis.

CloN6, a Novel Methyltransferase Catalyzing the Methylation of the Pyrrole‐2‐carboxyl Moiety of Clorobiocin.

In Vitro and in Vivo Production of New Aminocoumarins by A Combined Biochemical, Genetic, and Synthetic Approach

CloR, a Bifunctional Non-heme Iron Oxygenase Involved in Clorobiocin Biosynthesis

Combinatorial Biosynthesis, Metabolic Engineering and Mutasynthesis for the Generation of New Aminocoumarin Antibiotics

Structure-activity relationships of aminocoumarin-type gyrase and topoisomerase IV inhibitors obtained by combinatorial biosynthesis.

Metabolic engineering of the heterologous production of clorobiocin derivatives and elloramycin in Streptomyces coelicolor M512.